In addition, CEACAM1 was down-regulated in 30% of breast cancers compared to more than 90% of colon cancers, suggesting CEACAM1 delivered a strong growth inhibitory signal upon its expression in fully differentiated epithelial cells (Li et al., 2016). The gene discussed is CEACAM1; the disease is colonic neoplasm.